Compare Stocks: TXG, LUG, AGI, and EDV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGI Alamos Gold	$36.98 +1.4%	$32.55	$27.05 ▼ $55.41	$15.26B	0.61	3.67 million shs	2.14 million shs
EDV Vanguard Extended Duration Treasury ETF	$59.82 -0.8%	$60.78	$58.33 ▼ $71.31	$3.24B	0.69	1.22 million shs	2.51 million shs
LUG Lundin Gold	C$96.57 -1.1%	C$88.20	C$71.51 ▼ C$130.98	C$23.35B	1.643383	626,453 shs	806,831 shs
TXG 10x Genomics	$67.29 +2.6%	$52.54	$11.16 ▼ $67.62	$8.55B	2.08	2.61 million shs	2.76 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGI Alamos Gold	+1.39%	+2.34%	+11.21%	+7.28%	+13.71%
EDV Vanguard Extended Duration Treasury ETF	-0.80%	-0.25%	+0.42%	-7.26%	-12.30%
LUG Lundin Gold	-1.07%	-0.92%	+5.43%	+27.08%	+3.10%
TXG 10x Genomics	+2.58%	+9.15%	+14.89%	+131.64%	+398.44%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGI Alamos Gold	$36.98 +1.4%	$32.55	$27.05 ▼ $55.41	$15.26B	0.61	3.67 million shs	2.14 million shs
EDV Vanguard Extended Duration Treasury ETF	$59.82 -0.8%	$60.78	$58.33 ▼ $71.31	$3.24B	0.69	1.22 million shs	2.51 million shs
LUG Lundin Gold	C$96.57 -1.1%	C$88.20	C$71.51 ▼ C$130.98	C$23.35B	1.643383	626,453 shs	806,831 shs
TXG 10x Genomics	$67.29 +2.6%	$52.54	$11.16 ▼ $67.62	$8.55B	2.08	2.61 million shs	2.76 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGI Alamos Gold	+1.39%	+2.34%	+11.21%	+7.28%	+13.71%
EDV Vanguard Extended Duration Treasury ETF	-0.80%	-0.25%	+0.42%	-7.26%	-12.30%
LUG Lundin Gold	-1.07%	-0.92%	+5.43%	+27.08%	+3.10%
TXG 10x Genomics	+2.58%	+9.15%	+14.89%	+131.64%	+398.44%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGI Alamos Gold	2.80	Moderate Buy	$47.50	28.45% Upside
EDV Vanguard Extended Duration Treasury ETF	0.00	N/A	N/A	N/A
LUG Lundin Gold	3.00	Buy	C$101.33	4.93% Upside
TXG 10x Genomics	2.24	Hold	$44.00	-34.61% Downside

Current Analyst Ratings Breakdown

Latest TXG, LUG, AGI, and EDV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	TXG 10x Genomics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$20.00 ➝ $68.00
9/1/2026	TXG 10x Genomics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$70.00
9/1/2026	TXG 10x Genomics	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$70.00
8/12/2026	TXG 10x Genomics	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$50.00 ➝ $65.00
8/10/2026	TXG 10x Genomics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$42.00 ➝ $47.00
8/10/2026	TXG 10x Genomics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$50.00 ➝ $60.00
8/10/2026	LUG Lundin Gold	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target		C$137.00 ➝ C$131.00
8/7/2026	TXG 10x Genomics	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$37.00 ➝ $40.00
8/7/2026	TXG 10x Genomics	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$50.00
8/7/2026	TXG 10x Genomics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$45.00 ➝ $50.00
7/27/2026	LUG Lundin Gold	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	C$105.00 ➝ C$100.00

(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGI Alamos Gold	$2.23B	6.95	$1.92 per share	19.21	$10.59 per share	3.49
EDV Vanguard Extended Duration Treasury ETF	N/A	N/A	N/A	N/A	N/A	N/A
LUG Lundin Gold	C$2.02B	11.57	C$8.94 per share	10.81	C$2.25 per share	42.93
TXG 10x Genomics	$642.82M	13.64	N/A	N/A	$6.24 per share	10.78

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGI Alamos Gold	$885.80M	$2.77	13.35	13.85	0.49	52.64%	19.28%	13.47%	10/28/2026 (Estimated)
EDV Vanguard Extended Duration Treasury ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LUG Lundin Gold	C$215.94M	C$3.85	25.08	N/A	N/A	46.31%	81.63%	17.59%	N/A
TXG 10x Genomics	-$43.54M	-$0.59	N/A	N/A	N/A	-12.18%	-9.33%	-7.30%	11/5/2026 (Estimated)

Latest TXG, LUG, AGI, and EDV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	LUG Lundin Gold	N/A	C$1.19	N/A	C$1.29	N/A	C$678.70 million
8/6/2026	Q2 2026	TXG 10x Genomics	-$0.2431	-$0.14	+$0.1031	-$0.14	$146.67 million	$151.04 million
7/29/2026	Q2 2026	AGI Alamos Gold	$0.52	$0.59	+$0.07	$0.64	$593.58 million	$594.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGI Alamos Gold	$0.16	0.43%	+7.39%	5.78%	N/A
EDV Vanguard Extended Duration Treasury ETF	$3.24	5.42%	N/A	N/A	N/A
LUG Lundin Gold	C$3.95	4.09%	N/A	102.60%	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Latest TXG, LUG, AGI, and EDV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/10/2026	LUG Lundin Gold	Quarterly	C$1.09	4.43%	9/10/2026	9/25/2026	9/25/2026
8/27/2026	AGI Alamos Gold	quarterly	$0.04	0.42%	9/10/2026	9/10/2026	9/24/2026
6/10/2026	LUG Lundin Gold	Quarterly	C$0.91	3.95%	6/10/2026	6/25/2026	6/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGI Alamos Gold	0.04	2.07	1.67
EDV Vanguard Extended Duration Treasury ETF	N/A	N/A	N/A
LUG Lundin Gold	N/A	2.27	1.41
TXG 10x Genomics	N/A	5.69	5.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGI Alamos Gold	64.33%
EDV Vanguard Extended Duration Treasury ETF	N/A
LUG Lundin Gold	24.66%
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
AGI Alamos Gold	0.46%
EDV Vanguard Extended Duration Treasury ETF	N/A
LUG Lundin Gold	58.72%
TXG 10x Genomics	8.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGI Alamos Gold	3,234	418.59 million	416.67 million	Optionable
EDV Vanguard Extended Duration Treasury ETF	N/A	54.17 million	N/A	Not Optionable
LUG Lundin Gold	1,893	241.81 million	N/A	Not Optionable
TXG 10x Genomics	1,240	130.29 million	118.77 million	Optionable

TXG, LUG, AGI, and EDV Headlines

Recent News About These Companies

10x Genomics (NASDAQ:TXG) Reaches New 52-Week High - Still a Buy?

September 9 at 1:59 PM | marketbeat.com

UBS Group Initiates Coverage on 10x Genomics (NASDAQ:TXG)

September 9 at 10:05 AM | marketbeat.com

Major Insider Move Shakes Up 10x Genomics

September 8 at 10:11 PM | tipranks.com

10x Genomics (NASDAQ:TXG) Director John Stuelpnagel Sells 20,000 Shares

September 8 at 9:07 PM | marketbeat.com

Public Employees Retirement System of Ohio Buys Shares of 69,970 10x Genomics $TXG

September 6, 2026 | marketbeat.com

10x Genomics (NASDAQ:TXG) Research Coverage Started at Royal Bank Of Canada

September 4, 2026 | americanbankingnews.com

10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?

September 3, 2026 | zacks.com

RBC Capital initiates coverage of 10x Genomics (TXG) with sector perform recommendation

September 2, 2026 | msn.com

Royal Bank Of Canada Upgrades 10x Genomics (NASDAQ:TXG) to "Hold"

September 2, 2026 | marketbeat.com

Proficio Capital Partners LLC Takes $781,000 Position in 10x Genomics $TXG

September 2, 2026 | marketbeat.com

10x Genomics Needs "Meaningful' Growth in Single-Cell Business, RBC Says

September 1, 2026 | finance.yahoo.com

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences

August 31, 2026 | zacks.com

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

August 31, 2026 | benzinga.com

10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,486 Shares

August 29, 2026 | insidertrades.com

North Star Asset Management Inc. Invests $988,000 in 10x Genomics $TXG

August 29, 2026 | marketbeat.com

Insider Selling: 10x Genomics (NASDAQ:TXG) CEO Sells $667,853.34 in Stock

August 28, 2026 | marketbeat.com

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

August 28, 2026 | prnewswire.com

10x Genomics (NASDAQ:TXG) Director Sells 2,207 Shares of Stock

August 27, 2026 | insidertrades.com

10x Genomics CEO Serge Saxonov Sells 18,545 Shares to Cover RSU Tax Withholding

August 27, 2026 | kalkinemedia.comK

10x Genomics (NASDAQ:TXG) Director Shehnaaz Suliman Sells 2,207 Shares of Stock

August 26, 2026 | marketbeat.com

Insider Selling: 10x Genomics (NASDAQ:TXG) Insider Sells 13,818 Shares of Stock

August 26, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TXG, LUG, AGI, and EDV Company Descriptions

Alamos Gold NYSE:AGI

$36.98 +0.53 (+1.45%)

Closing price 09/9/2026 03:59 PM Eastern

Extended Trading

$36.75 -0.23 (-0.62%)

As of 09/9/2026 07:31 PM Eastern

Alamos Gold Inc. engages in the acquisition, exploration, development, and extraction of precious metals in Canada and Mexico. The company primarily explores for gold deposits. It holds 100% interest in the Young-Davidson mine and Island Gold mine located in the Ontario, Canada; Mulatos mine located in the Sonora, Mexico; and Lynn Lake project situated in the Manitoba, Canada. The company also holds interest in the Quartz Mountain project located in the Oregon United states. Alamos Gold Inc. was founded in 2003 and is based in Toronto, Canada.

Vanguard Extended Duration Treasury ETF NYSEARCA:EDV

$59.82 -0.48 (-0.80%)

Closing price 09/9/2026 04:10 PM Eastern

Extended Trading

$59.92 +0.10 (+0.17%)

As of 09/9/2026 07:39 PM Eastern

Vanguard Extended Duration Treasury ETF (the Fund) is an exchange-traded share class of Vanguard Extended Duration Treasury Index Fund. The Fund employs a passive management or indexing investment approach designed to track the performance of the Bloomberg Barclays U.S. Treasury STRIPS 20-30 Year Equal Par Bond Index. The Index measures the investment return of Treasury STRIPS, coupon and principal, with maturities ranging from 20 to 30 years. A Treasury STRIP represents a single coupon payment, or a single principal payment, from a United States Treasury security that has been stripped into separately tradable components. The Fund will invest at least 80% of its assets in the United States Treasury securities held in its target Index. The Fund may invest in derivatives. The Vanguard Group, Inc., through its Fixed Income Group, serves as the investment advisor of the Fund.

Lundin Gold TSE:LUG

C$96.57 -1.04 (-1.07%)

As of 09/9/2026 04:16 PM Eastern

Lundin Gold, headquartered in Vancouver, Canada, owns the Fruta del Norte gold mine in southeast Ecuador. Fruta del Norte is among the highest-grade operating gold mines in the world. The Company's board and management team have extensive expertise and are dedicated to operating Fruta del Norte responsibly. The Company operates with transparency and in accordance with international best practices. Lundin Gold is committed to delivering value to its shareholders through operational excellence and growth, while simultaneously providing economic and social benefits to impacted communities, fostering a healthy and safe workplace and minimizing the environmental impact. Furthermore, Lundin Gold is focused on continued exploration on its extensive and highly prospective land package to identify and develop new resource opportunities to ensure long-term sustainability and growth for the Company and its stakeholders.

10x Genomics NASDAQ:TXG

$67.29 +1.69 (+2.58%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$67.55 +0.26 (+0.39%)

As of 09/9/2026 07:57 PM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TXG, LUG, AGI, and EDV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TXG, LUG, AGI, and EDV Earnings

Compare Dividends

Latest TXG, LUG, AGI, and EDV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TXG, LUG, AGI, and EDV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TXG, LUG, AGI, and EDV Company Descriptions

Alamos Gold NYSE:AGI

Vanguard Extended Duration Treasury ETF NYSEARCA:EDV

Lundin Gold TSE:LUG

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools